Regarding Gravol for patients over 65 years. The age condition was removed, but the treatment section states that gravol may be considered for patients over the age of 65 if ondansetron is “unavailable.” My question: would it still be a patch to BHP if ondansetron is available, but Gravol would be the more appropriate antiemetic? Example being vertigo symptoms where the pt can’t even consume the PO ondansetron, but technically it is “available.”

In the analgesia directive, along with the nausea/vomiting directive is has “unaltered” as a condition. Is this written for the acutely altered patient who has a TBI for example? If we have a patient with a baseline GCS of let’s say 13-14 with dementia who presents with pain and/or N/V but no decrease in baseline mental status, is a patch required, or are they considered unaltered from baseline?

If the patient has a mint allergy, is Ondansetron contraindicated? On the package for Ondansetron package it says it contains mint.